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EVIDENCE BASED NEURO-ONCOLOGY
Role of Intra-operative MRI (iMRI) in Improving Extent of Resection and Survival
in Patients with Glioblastoma Multiforme
Inamullah Khan, Muhammad Waqas, Muhammad Shahzad Shamim

Abstract
Multiple intraoperative aids have been introduced to
improve the extent of resection (EOR) in Glioblastoma
Multiforme (GBM) patients, avoiding any new
neurological deficits. Intraoperative MRI (iMRI) has been
debated for its utility and cost for nearly two decades in
neurosurgical literature. Review of literature suggests
improved EOR in GBM patients who underwent iMRI
assisted surgical resections leading to higher overall
survival (OS) and progression free survival (PFS). iMRI
provides real time intraoperative imaging with reasonable
quality. Higher risk for new postoperative deficits with
increased EOR is not reported in any study using iMRI. The
level of evidence regarding prognostic benefits of iMRI is
still of low quality.
Keywords: Glioblatoma, iMRI, Extent of resection, Overall
survival, Progression free survival.

Figure: Intraoperative MRI.11

Introduction

progression free survival on PubMed database. Search
result showed a total of 33 articles, out of which seven
most relevant to the review objectives were selected for
the study by abstract screening. The reviewed articles
included three prospective cohorts, a retrospective
cohort, a meta-analysis and two systematic reviews
including a Cochrane review.

Maximum safe surgical resection followed by
concomitant chemotherapy and radiation therapy is the
standard of care for most Glioblastoma Multiforme (GBM)
patients. Extent of tumour resection (EOR) has been
shown by several studies, to be an independent predictor
of outcome.1,2 Several intra-operative aids have been
used to maximize the EOR, including cheaper options
such as ultrasound, awake craniotomy, and more
expensive ones such as neuronavigation and iMRI. iMRI
can provide better details of distortions caused by dural
opening and brain shift in comparison to neuronavigation
and is in use and under debate for nearly two decades.3
The major argument against its use is the cost. In this
article we review the present evidence of use of iMRI in
GBM resection and its impact on the EOR and survival in
such patients.

Review of Evidence
We conducted literature search on the use of iMRI in GBM
resection and its impact on EOR, overall survival and
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In one of the earliest publications on this topic, Black et al.,
in 1997 reported the use of iMRI in neurosurgical
procedures and inferred that iMRI helps in precise
localization and targeting of the lesion with immediate
evaluation of the progress of the procedure. iMRI also
decreases the potential errors of frame-based and
frameless stereotactic surgery due to altering position
with shifting brain parenchyma, helping to determine
tumour margins, optimizing the surgical approaches, and
achieving complete resection as well as monitoring
intraoperative complications.3 In 2009 Lenaburg et al.,
reviewed a series of 35 cases that underwent GBM
resection using iMRI and reported an average resection of
94% with only 3 patients in less than 90% resection range,
hence reporting a higher EOR with iMRI speculating
higher survival time in such patients.4
Senft et al., in 2010 reported a prospective analysis of a
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total of 103 GBM patients undergoing iMRI-assisted
resection from 2004 to 2009. iMRI identified residual
tumour tissue in 49.5% patients, which led to further
resection in 30.1% of the patients. Analysis of OS revealed
better outcomes in patients with complete resection
compared to patients with residual tumour (50% OS at
57.8 weeks vs. 33.8 weeks, p=0.003). They reported no
association of extent of resection to rate of neurological
deficits.5 In a systematic review, Kubben reported level 2
evidence for iMRI assisted surgery being more effective
than conventional neuronavigation-guided procedures in
terms of EOR, and OS after GBM resection.6

reported higher rates of PFS with iMRI (odds ratio, 1.84;
95% CI of 1.15 to 2.95; P= 0.012), although the OS was
similar for the two groups.10

In June 2013, Li Fy reported a prospective cohort study
consisting of 76 GBM patients who underwent iMRI and
multimodal navigation assisted resection. iMRI confirmed
31.6% cases of misestimated gross total resection (GTR)
by neurosurgeons and improved rates of gross total
resection (GTR) from 52.6% to 78.9% (χ(2) = 11.692, P =
0.001) with total resection achieved in 26.3% of the cases.
Higher PFS and OS were reported in total resection
compared to subtotal resection (PFS: 12 vs 9 months; χ2 =
4.756, P = 0.029) (OS: 16 vs 12 months; χ2 = 7.885, P =
0.005). The 2-year overall survival rate was 19.7%.7
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According to a Cochrane review the current evidence
regarding intraoperative imaging is of low quality, but
increased EOR in GBM is reported with iMRI. The report
suggests less clear benefit of iMRI on OS and PFS, which
could probably be confounded by the postoperative
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total resection were seen in iMRI (74%) compared to 5ALA assisted surgery (46%, p = 0.05) or white light surgery
(13%, p = 0.03). Six-months-PFS was reported at 45% in
total resection compared to 32% in subtotal resections.9
In December 2016, Li P et al., reported a meta-analysis
comparing iMRI to conventional neuronavigation in GBM
resection. Higher rates of GTR were associated with iMRI
compared to neuronavigation assisted resection (3.16,
95% confidence interval [CI] 2.07-4.83, P<0.001). They also
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Conclusion
Review of evidence identifies the prognostic benefit of
iMRI in GBM resection. Multiple studies report higher EOR
in iMRI assisted GBM resections, resulting in improved OS
and PFS. The level of evidence is however still of low
quality. The cost and logistical requirements at the
moment restrict the widespread utilization of iMRI,
especially in developing countries.
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